AdvanSix (NYSE:ASIX) versus ASP Isotopes (NASDAQ:ASPI) Financial Contrast

ASP Isotopes (NASDAQ:ASPI) and AdvanSix (NYSE:ASIX) are both small-cap materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and price targets for ASP Isotopes and AdvanSix, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1	0	2	0	2.33
AdvanSix	1	2	0	0	1.67

ASP Isotopes presently has a consensus price target of $13.00, suggesting a potential upside of 200.93%. AdvanSix has a consensus price target of $21.50, suggesting a potential upside of 28.60%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, analysts clearly believe ASP Isotopes is more favorable than AdvanSix.

Earnings and Valuation

This table compares ASP Isotopes and AdvanSix”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85 million	27.77	-$175.09 million	($2.08)	-2.08
AdvanSix	$1.56 billion	0.29	$49.29 million	($0.66)	-25.33

AdvanSix has higher revenue and earnings than ASP Isotopes. AdvanSix is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares ASP Isotopes and AdvanSix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
AdvanSix	-1.14%	-1.28%	-0.61%

Volatility and Risk

ASP Isotopes has a beta of 3.61, indicating that its stock price is 261% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.

Institutional and Insider Ownership

16.8% of ASP Isotopes shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by company insiders. Comparatively, 5.0% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

About AdvanSix

AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.